1. Home
  2. FBIO vs JLS Comparison

FBIO vs JLS Comparison

Compare FBIO & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • JLS
  • Stock Information
  • Founded
  • FBIO 2006
  • JLS 2009
  • Country
  • FBIO United States
  • JLS United States
  • Employees
  • FBIO N/A
  • JLS N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • JLS Investment Managers
  • Sector
  • FBIO Health Care
  • JLS Finance
  • Exchange
  • FBIO Nasdaq
  • JLS Nasdaq
  • Market Cap
  • FBIO 88.7M
  • JLS 103.4M
  • IPO Year
  • FBIO N/A
  • JLS N/A
  • Fundamental
  • Price
  • FBIO $3.00
  • JLS $18.88
  • Analyst Decision
  • FBIO Strong Buy
  • JLS
  • Analyst Count
  • FBIO 2
  • JLS 0
  • Target Price
  • FBIO $16.50
  • JLS N/A
  • AVG Volume (30 Days)
  • FBIO 1.6M
  • JLS 26.6K
  • Earning Date
  • FBIO 11-13-2025
  • JLS 01-01-0001
  • Dividend Yield
  • FBIO N/A
  • JLS 9.33%
  • EPS Growth
  • FBIO N/A
  • JLS N/A
  • EPS
  • FBIO N/A
  • JLS N/A
  • Revenue
  • FBIO $59,301,000.00
  • JLS N/A
  • Revenue This Year
  • FBIO $49.84
  • JLS N/A
  • Revenue Next Year
  • FBIO $42.47
  • JLS N/A
  • P/E Ratio
  • FBIO N/A
  • JLS N/A
  • Revenue Growth
  • FBIO N/A
  • JLS N/A
  • 52 Week Low
  • FBIO $1.33
  • JLS $15.48
  • 52 Week High
  • FBIO $4.20
  • JLS $17.97
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 45.50
  • JLS 44.35
  • Support Level
  • FBIO $2.72
  • JLS $18.47
  • Resistance Level
  • FBIO $3.24
  • JLS $19.03
  • Average True Range (ATR)
  • FBIO 0.29
  • JLS 0.32
  • MACD
  • FBIO -0.13
  • JLS -0.03
  • Stochastic Oscillator
  • FBIO 22.61
  • JLS 55.42

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

Share on Social Networks: